COH Analysis: Cochlear 2025 AGM Results |

Event: Cochlear 2025 AGM Results | Date: 2025-10-23 | Source: Cochlear Investor Relations

Strong Shareholder Support at Hybrid 2025 AGM

Cochlear Limited held its 2025 Annual General Meeting on 23 October 2025 in a hybrid format, with all resolutions passed by significant majorities, including the re-election of directors and approval of the long-term incentive plan. The company reported FY25 revenue of $2.4 billion, up 3% in constant currency terms, and underlying net profit of $392 million, a 1% increase, aligning with prior expectations. Management reiterated FY26 guidance for underlying net profit growth of 11-17% (5-11% adjusted for cloud investments), emphasising continued leadership in implantable hearing solutions through launches like the Nexa System, Kanso 3, and Baha 7. No new quantitative forecasts were provided beyond FY26, but updates highlighted emerging trade tensions as a risk, with higher inventory levels implemented to mitigate supply chain strains. For full details, see the ASX announcement.